KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Treasury Shares (2016 - 2025)

Cvs Health (CVS) has disclosed Treasury Shares for 17 consecutive years, with $36.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed 0.08% year-over-year to $36.8 billion, compared with a TTM value of $36.8 billion through Dec 2025, changed 0.08%, and an annual FY2025 reading of $36.8 billion, changed 0.08% over the prior year.
  • Treasury Shares was $516.0 million for Q4 2025 at Cvs Health, roughly flat from $516.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $519.0 million in Q1 2024 and bottomed at $39.7 million in Q2 2024.
  • Average Treasury Shares over 5 years is $454.6 million, with a median of $480.0 million recorded in 2023.
  • The sharpest move saw Treasury Shares dropped 0.28% in 2021, then grew 13.08% in 2022.
  • Year by year, Treasury Shares stood at $28.2 billion in 2021, then rose by 13.08% to $31.9 billion in 2022, then rose by 6.22% to $33.8 billion in 2023, then grew by 8.81% to $36.8 billion in 2024, then decreased by 0.08% to $36.8 billion in 2025.
  • Business Quant data shows Treasury Shares for CVS at $36.8 billion in Q4 2025, $36.8 billion in Q3 2025, and $36.8 billion in Q2 2025.